清栓酶治疗脑血栓冠心病微循环变化初步观察

本文报导40例脑心血管疾病在清栓酶治疗前后进行甲皱微循环对比观察,其中脑血栓组20例,冠心病组20例,两组均在清栓酶治疗2～3疗程后复查,分别对其甲皱微循环微血管袢的形态及功能,血液流态和微血管周围变化等三方面进行治疗前后对比观察,结果发现,治疗前甲皱微循环改变是明显的,临床症状较重,治疗后甲皱微循环障碍均得到了明显改善,临床症状也随着减轻或消失。治疗前后比较,其差异有显著的意义 P<0.05,P<0.01.从临床对比观察所见,脑心血管疾病的微循环改变与病情有关,其改变与病情轻重相吻合,与疾病转归相一致,提示微血管病变是动脉硬化临床可识别的象征.微循环障碍与疾病的发生发展有着内在联系,是脑心血管疾病的病因和发病的中间环节.治疗后微循环障碍的明显改善,提示清栓酶有着较好的改善微循环的功能.

OBSERVATION OF THE MICROCIRCULATION DYSFUNCTION CHANGES FOR CEREBRAL THROMBOSIS AND CORONARY HEART DISEASE TREATED WITH QINGSHUANEMEI

There is microcireulation dysfunction in varying degrees in cerebral thrombosis and coronary heart disease through clinical observation.It is often shown that vessel loop is elon- gated,arterio extremity is narrow,venous extremity is wide,blood stream is slow,segmental and there is hemo agglutination in vessel loop.It is also often shown that there are effusion and hemorrhage around vessel loop.Above-mentioned mierocirculation dysfunctions are obviously improved or disappear after the patients are treated with Qing shuanmei.